BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Integra LifeSciences (IART)Integra LifeSciencesEarnings

PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings

Related news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

IRMDiRadimed2026-07-24 20:15 EST

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

CVRXCVRx2026-07-23 20:30 EST

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

NEPHNephros2026-08-05 20:00 EST

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

AORTArtivion2026-07-23 20:10 EST

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

PLSEPulse Biosciences2026-07-21 20:05 EST

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

LUNGPulmonx2026-07-15 20:05 EST

Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

ADPTAdaptive Biotechnologies2026-07-09 20:05 EST

Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

IARTIntegra LifeSciences2026-07-02 12:30 EST

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

IARTIntegra LifeSciences2026-06-23 12:00 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Stock data

Close
17.10 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States